Skin Cancer in the Incarcerated Population-A Single-Center Study.
Adult
Aged
Aged, 80 and over
Biopsy
Carcinoma, Basal Cell
/ diagnosis
Carcinoma, Squamous Cell
/ diagnosis
Female
Humans
Male
Melanoma
/ diagnosis
Middle Aged
Prisoners
/ statistics & numerical data
Referral and Consultation
/ statistics & numerical data
Retrospective Studies
Skin
/ pathology
Skin Neoplasms
/ diagnosis
Tertiary Care Centers
/ statistics & numerical data
Time-to-Treatment
/ statistics & numerical data
Journal
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
ISSN: 1524-4725
Titre abrégé: Dermatol Surg
Pays: United States
ID NLM: 9504371
Informations de publication
Date de publication:
01 Jan 2022
01 Jan 2022
Historique:
pubmed:
6
10
2021
medline:
6
1
2022
entrez:
5
10
2021
Statut:
ppublish
Résumé
The incarcerated population may have variable access to specialty care that may affect the detection and diagnosis of skin cancer. The purpose of the study was to characterize skin cancers in the incarcerated population and determine time to treatment initiation (TTI) after biopsy. A retrospective cohort study was performed using data from a single-center referral hospital of incarcerated patients with biopsy-proven basal cell carcinoma (BCC), squamous cell carcinoma (SCC), or melanoma between January 2009 and December 2019. The main outcome measured was TTI after biopsy. One hundred thirteen patients, majority men (96.5%) and of Caucasian race (89.4%), were diagnosed and/or treated for 191 skin cancers. Of these 191 skin cancers, 118 were BCC (61.8%), 58 were SCC (30.4%), and 15 were melanomas (7.9%). The average TTI after biopsy for melanoma was 57 days (range: 21-136, median: 51, 95% confidence interval: 39.89-74.10) with an average Breslow depth of 1.57 mm. The average TTI of melanoma in the incarcerated population in this study was greater than 30 days, which may have increased mortality risk.
Sections du résumé
BACKGROUND
BACKGROUND
The incarcerated population may have variable access to specialty care that may affect the detection and diagnosis of skin cancer.
OBJECTIVE
OBJECTIVE
The purpose of the study was to characterize skin cancers in the incarcerated population and determine time to treatment initiation (TTI) after biopsy.
METHODS
METHODS
A retrospective cohort study was performed using data from a single-center referral hospital of incarcerated patients with biopsy-proven basal cell carcinoma (BCC), squamous cell carcinoma (SCC), or melanoma between January 2009 and December 2019. The main outcome measured was TTI after biopsy.
RESULTS
RESULTS
One hundred thirteen patients, majority men (96.5%) and of Caucasian race (89.4%), were diagnosed and/or treated for 191 skin cancers. Of these 191 skin cancers, 118 were BCC (61.8%), 58 were SCC (30.4%), and 15 were melanomas (7.9%). The average TTI after biopsy for melanoma was 57 days (range: 21-136, median: 51, 95% confidence interval: 39.89-74.10) with an average Breslow depth of 1.57 mm.
CONCLUSION
CONCLUSIONS
The average TTI of melanoma in the incarcerated population in this study was greater than 30 days, which may have increased mortality risk.
Identifiants
pubmed: 34608091
doi: 10.1097/DSS.0000000000003247
pii: 00042728-202201000-00004
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
17-20Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2021 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved.
Références
Booth JT. For prison inmates, healthcare comes slowly and unpredictably. America Jesuit Rev 2019;220:48.
Tanguay S, Trestman R, Weiskopf C. Patient health satisfaction survey in Connecticut correctional facilities. J Correct Health Care 2014;20:127–34.
Davis DM, Bello JK, Rottnek F. Care of incarcerated patients. Am Fam Physician 2018;98:577–83.
Omland SH, Ahlström MG, Gerstoft J, Pedersen G, et al. Risk of skin cancer in patients with HIV: a Danish nationwide cohort study. J Am Acad Dermatol 2018;79:689–95.
Louisiana Department of Public Safety and Corrections Fact Sheet. Available from: https://s32082.pcdn.co/wp-content/uploads/2020/08/Demographics-Jul-20.pdf . Accessed December 23, 2020.
Mathew P, Elting L, Cooksley C, Owen S, et al. Cancer in an incarcerated population. Cancer 2005;104:2197–204.
Linares MA, Zakaria A, Nizran P. Skin cancer. Prim Care 2015;42:645–59.
American Cancer Society. Key Statistics for Melanoma Skin Cancer 2020. Atlanta, GA: American Cancer Society; 2020.
Conic RZ, Cabrera CI, Khorana AA, Gastman BR. Determination of the impact of melanoma surgical timing on survival using the National Cancer Database. J Am Acad Dermatol 2018; 78:40–6.e7.
Adamson AS, Zhou L, Baggett CD, Thomas NE, et al. Association of delays in surgery for melanoma with insurance type. JAMA Dermatol 2017;153:1106–13.
Boczar D, Restrepo DJ, Sisti A, Huayllani MT, et al. Analysis of melanoma in african American patients in the United States. Anticancer Res 2019;39:6333–7.
Shaikh WR, Dusza SW, Weinstock MA, Oliveria SA, et al. Melanoma thickness and survival trends in the United States, 1989 to 2009. J Natl Cancer Inst 2015;108:djv294.
Lott JP, Narayan D, Soulos PR, Aminawung J, et al. Delay of surgery for melanoma among medicare beneficiaries. JAMA Dermatol 2015;151:731–41.
Carson EA, Sabol WJ. Aging of the State Prison Population, 1993–2013. Washington DC: Bureau of Justice Statistics; 2016.
Kakushadze Z, Raghubanshi R, Yu W. Estimating cost savings from early cancer diagnosis. Data 2017;2:30.
McKillop M. Prison Health Care Spending Varies Dramatically by State. The PEW Charitable Trusts. 2017. Available from: https://www.pewtrusts.org/en/research-and-analysis/articles/2017/12/15/prison-health-care-spending-varies-dramatically-by-state . Accessed September 3, 2020.